You are here

Scheduling delegate's interim decisions and invitation for further comment: ACCS/ACMS, December 2011

Scheduling of medicines & poisons

21 December 2011

Invitation for further submissions: closed 13 January 2012.

Interim decisions & reasons for decisions by the Delegate of the Secretary to the Department of Health and Ageing in response to ACCS#2, ACMS#3 - June 2011.

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Contents

  • December 2011 invitation for further submissions
  • Glossary
  • Interim decisions on proposals referred to an Advisory Committee
  1. October 2011 meeting of the Advisory Committee on Chemicals Scheduling (ACCS) - ACCS#3
    • 1.1 Ametoctradin
    • 1.2 Deltamethriin
    • 1.3 Fluxapyroxad
    • 1.4 Indaziflam
    • 1.5 Prosulfuron
    • 1.6 Dicamba
  2. October 2011 meeting of the Advisory Committee on Medicines Scheduling (ACMS) - ACMS#4
    • 2.1 Proposed changes to Part 2 of the SUSMP (Labels and Containers)
      • 2.1.1 Schedule 8 labelling requirements
    • 2.2 Proposed changes to Part 4 of the SUSMP (The Schedules)
      • 2.2.1 Azelastine
      • 2.2.2 Diclofenac
      • 2.2.3 Famciclovir
      • 2.2.4 Follistatin
      • 2.2.5 3, 4-Methylenedioxypyrovalerone (MDPV)
      • 2.2.6 Synthetic cannabinoids
      • 2.2.7 Piper methysticum (kava)
    • 2.2 Proposed changes to Part 5 of the SUSMP (The Appendices)
      • 2.2.1 Adrenaline
      • 2.3.2 Fingolimod